article thumbnail

Mapping the intersection of sudden cardiac death and COVID-19: a comprehensive bibliometric analysis (2020–2024)

Frontiers in Cardiovascular Medicine

Literature retrieved using the above keywords and published were included with a time limit from 1st January 2020 to 8th Aug 2024.ResultsThe ResultsThe bibliometric analysis of COVID-19 and Sudden Cardiac Death highlights key research trends from 2020 to 2024, revealing a rapid surge in scientific output during the pandemic.

article thumbnail

GLP-1 Agonist Scripts Jumped 600% for Teens, Young Adults Since 2020

Med Page Today

From 2020 to 2023, the number of individuals ages. (MedPage Today) -- The number of adolescents and young adults prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist increased nearly 600% over the past few years, pharmacy data indicated.

111
111
article thumbnail

Trends in Infective Endocarditis Mortality in the United States: 1999 to 2020: A Cause for Alarm

Journal of the American Heart Association

Between 1999 and 2020, the IE‐related age‐adjusted mortality rates declined. IE‐related crude mortality accelerated significantly in the age groups 25–34 years (average annual percentage change, 5.4 [95% P<0.001) and 35–44 years (average annual percentage change, 2.3 [95% 95% CI, −1.9

article thumbnail

Perinatal PTSD Diagnoses Rose 394 Percent From 2008 – 2020

HCPLive

The study found the odds of a perinatal PTSD diagnosis were greater for people aged 15 – 26 years, more comorbidities, and a lower income of poverty.

85
article thumbnail

Clinical Quiz: Urate-Lowering Therapy Recommendations from 2020 ACR Gout Guidelines

HCPLive

This clinical quiz tests your knowledge of recommendations related to the initiation and titration of urate-lowering therapy from the 2020 ACR guidelines for gout management.

59
article thumbnail

Top stories: Cardiac arrest—Patients at risk

HeartRhythm

Between 1998 and 2020, SCA rates dropped from 7.4% Patients recruited to these trials had left ventricular ejection fraction (LVEF) <40% following acute MI. with comparable median follow-up duration (VALIANT 24.7 months and PARADISE-MI 22 months).

article thumbnail

Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data

Open Heart

There was a reduction in all procedures across all pandemic periods, with the largest reductions during the first, most severe restriction period (23 March 2020 to 23 June 2020), and the relaxation period following second restrictions (3 December 2020 to 4 January 2021) coinciding with winter pressures. x 10 –08 ).